Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4824401000168112 | Rybrevant (amivantamab 350 mg / 7 mL) injection, 7 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4824411000168110 | Rybrevant 350 mg/7 mL injection, 7 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | Rybrevant | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | amivantamab 350 mg/7 mL injection, vial | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has intended active ingredient | amivantamab | true | Inferred relationship | Some | 613977832 | |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has Australian BoSS | amivantamab | true | Inferred relationship | Some | 613977832 | |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1918278479 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has TPUU | True | Rybrevant 350 mg/7 mL injection, 7 mL vial | Inferred relationship | Some | 1726020021 |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has TPUU | True | Rybrevant 350 mg/7 mL injection, 7 mL vial | Inferred relationship | Some | 1220908785 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR